Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

120.49
Delayed Data
As of Feb 17
 +0.31 / +0.26%
Today’s Change
60.30
Today|||52-Week Range
125.49
+20.17%
Year-to-Date

Today’s Trading

Previous close120.18
Today’s open120.18
Day’s range119.16 - 120.85
Volume941,388
Average volume (3 months)1,394,256
Market cap$22.8B
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+95.15%
Revenue growth (last year)+46.70%
P/E ratio152.5
Price/Sales17.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.05+0.12%
VRTXVertex Pharmaceutica...+0.63+0.72%
ZTSZoetis Inc-0.27-0.51%
BAXBaxter International...+0.31+0.63%
Data as of 4:01pm ET, 02/17/2017

Financials

Last reporting dateFebruary 14, 2017
EPS forecast (this quarter)$0.12
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts


Search for Jobs